An abbreviated tract of five thymidines (5T) in intron 8 of the cystic fibrosis transmembrane conductance regulator ( CFTR) gene is found in similar to 10% of individuals in the general population. When found in trans with a severe CFTR mutation, 5T can result in male infertility, nonclassic cystic fibrosis, or a normal phenotype. To test whether the number of TG repeats adjacent to 5T influences disease penetrance, we determined TG repeat number in 98 patients with male infertility due to congenital absence of the vas deferens, 9 patients with nonclassic CF, and 27 unaffected individuals ( fertile men). Each of the individuals in this study had a severe CFTR mutation on one CFTR gene and 5T on the other. Of the unaffected individuals, 78% ( 21 of 27) had 5T adjacent to 11 TG repeats, compared with 9% ( 10 of 107) of affected individuals. Conversely, 91% ( 97 of 107) of affected individuals had 12 or 13 TG repeats, versus only 22% ( 6 of 27) of unaffected individuals (P < .00001). Those individuals with 5T adjacent to either 12 or 13 TG repeats were substantially more likely to exhibit an abnormal phenotype than those with 5T adjacent to 11 TG repeats ( odds ratio 34.0, 95% CI 11.1 - 103.7, P < .00001). Thus, determination of TG repeat number will allow for more accurate prediction of benign versus pathogenic 5T alleles.

Groman, J.d., Hefferon, T.w., Casals, T., Bassas, L., Estivill, X., Des Georges, M., et al. (2004). Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. AMERICAN JOURNAL OF HUMAN GENETICS, 74(1), 176-179 [10.1086/381001].

Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign

NOVELLI, GIUSEPPE;
2004-01-01

Abstract

An abbreviated tract of five thymidines (5T) in intron 8 of the cystic fibrosis transmembrane conductance regulator ( CFTR) gene is found in similar to 10% of individuals in the general population. When found in trans with a severe CFTR mutation, 5T can result in male infertility, nonclassic cystic fibrosis, or a normal phenotype. To test whether the number of TG repeats adjacent to 5T influences disease penetrance, we determined TG repeat number in 98 patients with male infertility due to congenital absence of the vas deferens, 9 patients with nonclassic CF, and 27 unaffected individuals ( fertile men). Each of the individuals in this study had a severe CFTR mutation on one CFTR gene and 5T on the other. Of the unaffected individuals, 78% ( 21 of 27) had 5T adjacent to 11 TG repeats, compared with 9% ( 10 of 107) of affected individuals. Conversely, 91% ( 97 of 107) of affected individuals had 12 or 13 TG repeats, versus only 22% ( 6 of 27) of unaffected individuals (P < .00001). Those individuals with 5T adjacent to either 12 or 13 TG repeats were substantially more likely to exhibit an abnormal phenotype than those with 5T adjacent to 11 TG repeats ( odds ratio 34.0, 95% CI 11.1 - 103.7, P < .00001). Thus, determination of TG repeat number will allow for more accurate prediction of benign versus pathogenic 5T alleles.
2004
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/03 - GENETICA MEDICA
English
Con Impact Factor ISI
thymidine; transmembrane conductance regulator; agenesis; article; controlled study; cystic fibrosis; gene mutation; gene sequence; genetic screening; genetic variability; human; major clinical study; male; male infertility; mass screening; nucleotide repeat; pathogenicity; phenotype; priority journal; regulator gene; vas deferens; Base Sequence; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dinucleotide Repeats; Genotype; Humans; Male; Mutation; Phenotype; Reference Values; Variation (Genetics)
Groman, J.d., Hefferon, T.w., Casals, T., Bassas, L., Estivill, X., Des Georges, M., et al. (2004). Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. AMERICAN JOURNAL OF HUMAN GENETICS, 74(1), 176-179 [10.1086/381001].
Groman, Jd; Hefferon, Tw; Casals, T; Bassas, L; Estivill, X; Des Georges, M; Guittard, C; Koudova, M; Fallin, Md; Nemeth, K; Fekete, G; Kadasi, L; Friedman, K; Schwarz, M; Bombieri, C; Pignatti, Pf; Kanavakis, E; Tzetis, M; Schwartz, M; Novelli, G; D'Apice, Mr; Sobczynska Tomaszewska, A; Bal, J; Stuhrmann, M; Macek, J; Claustres, M; Cutting, Gr
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/30260
Citazioni
  • ???jsp.display-item.citation.pmc??? 57
  • Scopus 221
  • ???jsp.display-item.citation.isi??? 191
social impact